Molecular diagnosis in patients with monogenic diabetes mellitus, and detection of a novel candidate gene

Diabetes Res Clin Pract. 2023 Nov:205:110953. doi: 10.1016/j.diabres.2023.110953. Epub 2023 Oct 13.

Abstract

Aim: We aimed to investigate molecular genetic basis of monogenic diabetes (DM) and novel responsible candidate genes with targeted Next Generation Sequencing (NGS) and Whole Exome Sequencing (WES).

Methods: A hundred cases presenting with clinical findings and a family history of monogenic DM were included in the study. Molecular analysis was performed using an NGS panel including 14 genes. Following targeted NGS, WES was planned in cases in whom no variant was detected.

Results: Thirty different disease-causing variants in seven different genes were detected in thirty-five (35 %) cases with targeted NGS approach. Most common pathogenic variant was found in GCK gene in 25 (25 %) cases. Four different variants were detected in 4 (4 %) patients in ABCC8 gene. In 45 of 65 cases; WES analyses were done. A heterozygous c.2635C > T(p.Gln879Ter) variant was detected in IFIH1 gene in a patient with incidental hyperglycemia. In the segregation analysis affected mother was shown to be heterozygous for the same variant.

Conclusion: Molecular etiology was determined in 35 % cases with the NGS targeted panel. Seventeen novel variants in monogenic DM genes have been identified. A candidate gene determined by WES analysis in a case that could not be diagnosed with NGS panel in this study.

Keywords: IFIH1; Monogenic diabetes; Targeted next generation sequencing analysis (NGS); Whole exome sequencing (WES).

MeSH terms

  • Diabetes Mellitus* / diagnosis
  • Diabetes Mellitus* / genetics
  • Genetic Testing
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Mutation